samedan logo
 
 
spacer
home > ict > summer 2018 > navigating global complexities
PUBLICATIONS
International Clinical Trials

Navigating Global Complexities

Insurance is a small part of the global clinical trial process, but it can have a huge impact on the contract or clinical research company’s efforts geared towards ensuring trials proceed smoothly.

Making sure a clinical trial’s insurance policy stands up to the scrutiny of the ethics committee in each territory is essential. Inappropriate insurance documentation presented to the ethics committee meeting could delay the onset of the trial until at least their next meeting, reducing the patent exclusivity period, potentially costing millions of pounds and negatively affecting important business relationships.

Having a sound understanding of the legislation and regulations governing clinical trials in the territory where the company is testing is the best starting point.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Kathryn Moon is ACII qualified and has worked in the insurance industry for over 20 years in a variety of roles including Account Broker, Project Manager, Development Manager, and Account Executive. She is currently Managing Director of the Coventry office of Gallagher – the global insurance broker, risk management services, and consulting firm – and an integral part of its UK life sciences specialism. Gallagher are also members of OBN.
spacer
Kathryn Moon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

2019 Pharmapack Awards

Pharmapack Europe have announced entries for the 2019 Pharmapack Awards are now open across both the ‘Exhibitor Innovation’ and ‘Health Products’ categories with a closing date of 30th November 2018. The Health Products category will include two winners with one for Patient-Centric Design – which is launched in partnership with HCPC Europe (Healthcare Compliance Packaging Council of Europe) – and a second introduced alongside Adelphe for Eco-design in health packaging and drug delivery devices. Pharmapack Europe have also announced that they’re accepting applications for the start-up hub which provides young start-up companies servicing the pharma industry with the benefit of valuable networking and learning opportunities at half the price of a regular stand.
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement